The FDA first approved Dignitana’s DigniCap Cooling System in 2015 for breast cancer patients. The cooling cap may now also be used for cancer patients with solid tumors.
Patients wear the cap during chemotherapy sessions. The device circulates cold liquid to cool the scalp and restrict blood flow to the head, thereby limiting the amount of chemotherapy that reaches the scalp and harms hair follicles.
More articles on supply chain:
Precision benchmarking a panacea for purchased services savings
Vertex Pharma makes 1st price hike on cystic fibrosis drug
Novo Nordisk recalls insulin pen cartridge holders
